Prevention of thromboembolic disease after latest quidelines

Abstract

Venous thrombosis, risk factors, fondararinux, dabigatran, rivaroxaban, extension of postoperative prophylaxis

Keywords

• Venous thrombosis
• risk factors
• fondararinux
• dabigatran
• rivaroxaban
• extension of postoperative prophylaxis